UBS Group’s Colony Capital, Inc. CLNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-55,090
Closed -$1.12M 8395
2016
Q4
$1.12M Sell
55,090
-18,211
-25% -$357K ﹤0.01% 3455
2016
Q3
$1.34M Sell
73,301
-15,387
-17% -$272K ﹤0.01% 3198
2016
Q2
$1.36M Sell
88,688
-85,423
-49% -$1.48M ﹤0.01% 3113
2016
Q1
$2.92M Sell
174,111
-8,720
-5% -$147K ﹤0.01% 2344
2015
Q4
$3.56M Sell
182,831
-437,047
-71% -$8.9M ﹤0.01% 2259
2015
Q3
$12.1M Sell
619,878
-315,074
-34% -$6.98M 0.01% 1234
2015
Q2
$21.2M Buy
934,952
+215,618
+30% +$5.48M 0.01% 951
2015
Q1
$18.6M Sell
719,334
-497,260
-41% -$12.5M 0.01% 1011
2014
Q4
$29M Buy
+1,216,594
New +$28.3M 0.02% 784

Other funds holding CLNY

UBS Group's CLNY Position: Q1 2017 in Review

UBS Group sold out of Colony Capital, Inc. (CLNY) in Q1 2017, closing a stake of 55,090 shares — an estimated $1.12M sold.

UBS Group first reported a position in CLNY in Q4 2014 and held it in 9 quarters. The position peaked at $29M in Q4 2014. 2 funds tracked by Wall St. Rank hold CLNY as of Q1 2017.

  • UBS Group reported no remaining Colony Capital, Inc. position as of Q1 2017 after selling out during the quarter.
  • UBS Group sold 55,090 Colony Capital, Inc. shares in Q1 2017, an estimated $1.12M.
  • UBS Group first reported a position in Colony Capital, Inc. in Q4 2014 and held it in 9 quarters.
  • UBS Group's Colony Capital, Inc. position peaked at $29M in Q4 2014.
  • 2 funds tracked by Wall St. Rank held Colony Capital, Inc. as of Q1 2017.

Based on UBS Group's 13F filing for Q1 2017, filed 12 May 2017.